|
|
Volumn 35, Issue 2, 2003, Pages 791-
|
|
Conversion to sirolimus after kidney and liver transplantation: Indications and outcomes
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CALCINEURIN INHIBITOR;
CREATININE;
CYCLOSPORIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MACROLIDE;
PREDNISONE;
RAPAMYCIN;
TACROLIMUS;
ABSCESS;
ADULT;
AGED;
ARTHRALGIA;
BRAIN INFARCTION;
CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DEPRESSION;
DOSE RESPONSE;
DRUG DOSE REDUCTION;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG TOLERABILITY;
FOLLOW UP;
GRAFT REJECTION;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
HYPERLIPIDEMIA;
HYPERPARATHYROIDISM;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DYSFUNCTION;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
MOUTH LESION;
MULTIPLE ORGAN FAILURE;
NEPHROTOXICITY;
PAIN;
PRIORITY JOURNAL;
SIDE EFFECT;
THROMBOCYTOPENIC PURPURA;
TREATMENT OUTCOME;
URINARY TRACT INFECTION;
|
|
EID: 0037339058
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(03)00046-0 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
